Navigation Links
Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
Date:11/9/2007

are expected in the second half of 2008.

Pharmion recently initiated an international pivotal Phase 3 trial of Amrubicin versus topotecan as second-line treatment of small cell lung cancer (sensitive or refractory and limited or extensive disease). The randomized, controlled, multi-center study will compare Amrubicin to topotecan, the only approved chemotherapy for second-line treatment of SCLC in the US and EU. The primary endpoint of the study is overall survival. Enrollment in the study of 480 patients is underway. Pharmion has completed the Scientific Advice (SA) process with the European Medicines Agency (EMEA) and has reached Special Protocol Assessment (SPA) agreement with the US Food and Drug Administration (FDA) for the Amrubicin Phase 3 SCLC study.

About Amrubicin

Pharmion acquired the rights to Amrubicin in November 2006 through its acquisition of Cabrellis Pharmaceuticals. In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both SCLC and NSCLC. Since January 2005, Amrubicin has been marketed by Nippon Kayaku, a Japanese pharmaceutical firm focused on oncology, which licensed Japanese marketing rights from Dainippon Sumitomo, the original developer of Amrubicin.

About Small Cell Lung Cancer

Small cell lung cancer is a disease in which malignant cells form in the tissues of the lung, and which occurs almost exclusively in people who smoke. While small cell lung cancer constitutes approximately 15 percent of all lung cancers, SCLC tends to be more aggressive and fast growing than the more common non-small cell lung cancer. Of the estimated 62,000 patients diagnosed with SCLC each year in the US and EU, approximately 60 percent of patients have extensive disease at diagnosis, and the remaining 40 percent present with localized, or limited stage, disease.

About Pharmion

Pharmion is a leading global oncology company uniquely focused on acquiring, developing and commercializi
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
5. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
6. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
7. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
8. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
9. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
10. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
11. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015  New York College of Health Professions ... Properties portfolio with U.S. Patent #8,996,098 donated by its ... represents a surgical instrument that allows surgeons to view ... were in the traditional format of a slide that ... databases during surgery, thus providing the surgeon real time ...
(Date:3/30/2015)... OF PRUSSIA, Pa. , March 30, 2015 ... the European Medicines Agency (EMA) has started the ... Application (MAA) for its long-acting fusion protein linking ... Upon European Commission approval, rIX-FP will provide hemophilia ... well as the European Economic Area (EEA) countries, ...
(Date:3/30/2015)... Israel , March 30, 2015   GlassesUSA , ... the closing of $12.5 million in new financing led by ... Group. The funding will further GlassesUSA,s aggressive business growth and ... global market of online eyewear, both B2C and B2B. ... Rothman , COO Eldad Rothman , and CTO ...
Breaking Medicine Technology:World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 2European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 3European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 4GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... Eli Lilly and Company (NYSE: LLY ) will announce its ... 2010 .  Lilly will also conduct a conference call on that day with ... , , , ... from 9:00 a.m. to 10:00 a.m. EDT .  Investors, media and the ...
... RALEIGH, N.C. , July 9 Pioneer Surgical Technology, ... technical biologic expertise to support their growing line of products that address ... , , ... stated, "We are extremely pleased with our ability to provide innovative biologic ...
Cached Medicine Technology:Lilly Confirms Date and Conference Call for Second-Quarter 2010 Financial Results Announcement 2Pioneer® Surgical Expands Product Specialists to Support Growing Biologics Business 2
(Date:3/30/2015)... Falls Church, VA (PRWEB) March 31, 2015 ... two of the industry’s most respected inspection readiness ... workshop that walks attendees through the inspection process. ... FDA or national authority investigator and what they ... techniques include interactive role-playing exercises and roundtable discussions. ...
(Date:3/30/2015)... 2015 NAPW honors ... Hands Warm Hearts, as a 2015 Professional Woman of ... for leadership in home health services. As the largest, ... every industry and profession, the National Association of Professional ... nearly 700,000 members and over 200 Local Chapters. , ...
(Date:3/30/2015)... San Diego, CA (PRWEB) March 30, 2015 ... provider, is proud to announce the start of its ... and bestselling author Jane McGonigal, and former Congressman Patrick ... In Recovery Conference being held in San Diego, ... Hotel Del Coronado. The national conference brings together leading ...
(Date:3/30/2015)... Pass, OR (PRWEB) March 30, 2015 ... and other drought stricken areas are scrambling to make ... Kleyne would those individuals to be aware that when ... can also lose water and become dehydrated. Kleyne calls ... it. , Kleyne talked about weather, body drought ...
(Date:3/30/2015)... Houston, Texas (PRWEB) March 30, 2015 Health ... 1 Fitness Trainer in the World Samir Becic, has created ... of State 2015 , which recognizes the world’s fittest leaders ... is the first and only list of its kind to ... and prime ministers. , Among the world leaders profiled on ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 2Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 3Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 4Health News:National Association of Professional Women Announces Rachel L. Gregus, Manager / Co-Founder of Safe Hands Warm Hearts, a 2015 Professional Woman of the Year 2Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:As California Dry Season Approaches, Risk of Body Drought Increases, Warns Fresh Water Advocate 2Health News:As California Dry Season Approaches, Risk of Body Drought Increases, Warns Fresh Water Advocate 3Health News:The Top 13 Fittest Heads of State: Why Putin Might Be No. 1 in Health and Fitness 2
... the parents of an estimated one in 20,000 newborns are ... dystrophy (CDM1), a progressive and crippling genetic disorder. Although ... prenatal tests are available, many children are not diagnosed until ... that they have type 1 myotonic dystrophy (DM1) a ...
... When actress Sally Field was diagnosed with osteoporosis in 2005, ... eaten right, I had always exercised, and I had always ... tried to be a good girl all the way down ... ,Field was in town to talk to legislators at ...
... there, it is generally believed. And its death dance continues ... medicines is also denied the unfortunate people. ... from 100,000 in 2003 to 1.3 million last year, but ... drug programs, according to the report released Thursday by Medecins ...
... pay for badly needed restorations, are reaching out to the ... bird-watching lectures, Sunday jazz concerts, brunches with star chefs, Halloween ... ,The cemetery tourism fever is catching on. ... Titanic made many gasp for breath. It looked as if ...
... University of Jerusalem says that he has observed the real ... ever claim of such kind in the world. ... Alexander Silberman Institute of Life Sciences, used mouse models to ... a rich and complex cell. ,The new findings ...
... has discovered a cocktail of enzymes that converts starchy syrups ... fed into a fuel cell to run an electric car, ... ,The method hinges on a mixture of 13 ... but never together in nature. ,According to ...
Cached Medicine News:Health News:Researcher Studying Disease That Cripples Newborns 2Health News:Actress Sally Field Vows to Fight Against Osteoporosis 2Health News:Actress Sally Field Vows to Fight Against Osteoporosis 3Health News:Shortage of Doctors and Nurses Affects AIDS Treatment in Africa 2Health News:Shortage of Doctors and Nurses Affects AIDS Treatment in Africa 3Health News:Cemetery Tourism, the New Catchword in US 2Health News:Scientist Observes real Time Generation of Neurones in Mammals 2Health News:Researchers Discover Starch Cocktail Fuel for green Car 2
Stereo Smile II also includes a blank card and tests,at 60, 120, 240 and 480 sec of arc., ,Smile Test II Includes:, 1 demonstration card, 1 pair pediatric 3-D viewers, 1 pair infant 3-D v...
... Smile Tests at 480 and 120 ... for children of 6,months to 5 years ... ,Stereo Smile Tests screen for:, Amblyopia, Strabismus, ... Test Includes:, 1 demonstration card, 1 pair ...
... Random Dot Stereo Depth Perception for ... of arc) and Fine Depth,Perception. , ... (800 to 40 sec of arc), ... to 100 sec of arc), 1 ...
... Depth Perception. Test and Evaluate,Both Gross ... and Fine Depth Perception., ,The Test ... 40 sec of arc), Animal Test ... of arc), 1 Pair of Standard ...
Medicine Products: